BIOMAT Database Logo BIOMAT Database Logo

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. 2009

Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Neurological Clinic, Ortenau-Klinikum, Offenburg, Germany.

We describe the clinical and therapeutic course of a 52-year-old patient with multiple sclerosis in whom progressive multifocal leukoencephalopathy (PML) developed after 12 months of therapy with natalizumab. The patient was hospitalized 2 months after the onset of neurologic and psychiatric symptoms and was treated with plasma exchange and immunoadsorption to eliminate natalizumab. After a brief improvement, he became critically ill with an apparent episode of immune reconstitution inflammatory syndrome. Steroid-pulse therapy led to stabilization of the patient's condition and clinically significant recovery. This case illustrates that prompt diagnosis and treatment may improve the outcome in patients with severe PML associated with natalizumab therapy.

UI MeSH Term Description Entries
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Natalizumab-associated progressive multifocal leukoencephalopathy.
August 2012, The New England journal of medicine,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Natalizumab-associated progressive multifocal leukoencephalopathy.
August 2012, The New England journal of medicine,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.
February 2013, Journal of neurology,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
May 2012, The New England journal of medicine,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
July 2015, Brain and nerve = Shinkei kenkyu no shinpo,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Natalizumab-associated progressive multifocal leukoencephalopathy in Germany.
May 2019, Neurology,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.
May 2011, Neurology,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Progressive multifocal leukoencephalopathy and natalizumab.
November 2011, Journal of neurology,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Natalizumab-induced progressive multifocal leukoencephalopathy.
July 2014, Clinical nuclear medicine,
Werner Wenning, and Aiden Haghikia, and Jörg Laubenberger, and David B Clifford, and Peter F Behrens, and Andrew Chan, and Ralf Gold
Natalizumab and progressive multifocal leukoencephalopathy.
July 2005, The New England journal of medicine,
Copied contents to your clipboard!